Use our portfolio of research and diagnostic tools to gain deeper insights from your COVID-19 samples.
If COVID-19 were a person, they would stand accused of one of the most heinous crimes against humanity. They would be apprehended and interrogated using every technique known to mankind.
Our new COVID-19 toolbox contains several tests that generate additional data to understand the novel coronavirus SARS-CoV-2. This includes our new test for antibody detection, offering novel insights together with the previously available kits for general research into infectious disease and cellular responses.
If your library preparation kit isn’t specifically designed for viral pathogen sequencing, then you’re probably missing data. Revelo RNA-Seq is an integrated NGS library preparation and QC solution that provides exceptional sensitivity to identify and characterize pathogens from low quality samples, such as nasal swabs.
Read moreWas that sample really negative? Or did your current protocol just fail to detect it? RNA isolated from COVID-19 nasal swab samples can vary significantly in quantity, quality and viral titers, making it difficult to interrogate.
Read moreHMGB1 is involved in intracellular signaling, immune regulation, inflammation and cell death. With this functional repertoire, HMGB1 is a promising biomarker that may deepen, and even change, our understanding of COVID-19 disease development.
Read moreNeopterin can serve as a biomarker for infection of the body by invading pathogens. Neopterin concentrations rise before symptoms are present, and decrease as the immune system starts to produce antibodies. This makes it an ideal marker for detecting potential pathogen invasion, which could include SARS-CoV-2.
Read moreSerological testing of IgG antibodies directed against SARS-CoV-2 plays an essential role in determining the prevalence of the virus. Efficient immune status monitoring can be used for prescreening of individuals before vaccination, as well as for investigating post-vaccination responses.
Read more